Investing Experts Making money in biotech stocks
8 snips
Oct 9, 2025 In this discussion, Jonathan Faison, founder of the ROTY Biotech Community and biotech investing strategist, shares his insights on trading in the biotech sector. He reveals different investment strategies, including theme-based trading and managing sector risk. Jonathan emphasizes the importance of focusing on late-stage companies and offers a fascinating case study on Syndax Pharmaceuticals. He also discusses navigating regulatory risks and highlights Geron as a promising undervalued biotech with great potential. Tune in for his expert advice!
AI Snips
Chapters
Transcript
Episode notes
Position Size And Slow Trading
- Use strict position-sizing rules to limit single-stock risk in biotech portfolios.
- Trade sparingly and focus on multi-year outcomes rather than daily moves.
Use Community Feedback Actively
- Invite criticisms and opposing views to improve your investment thesis.
- Use community feedback to create pre-trade rules and exercises like cage matches to choose winners.
Many Paths To Profits In Biotech
- Multiple ways exist to make money in biotech: thematic, value, or binary-event trades.
- Late-stage and commercial-stage companies reduce regulatory binary risk and fit his edge.